Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bupivacaine Injection of Eye Muscles to Treat Strabismus

NCT01616108 is registered in ClinicalTrials.gov with Smith-Kettlewell Eye Research Institute as lead sponsor.

NCT NCT01616108
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01616108 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bupivacaine Injection of Eye Muscles to Treat Strabismus
Lead sponsor
Smith-Kettlewell Eye Research Institute
Phase
Phase 2/3
Overall status
Unknown status
Start date
April 30, 2012
Completion date
September 30, 2020
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esotropia, exotropia, graves disease, ptosis, eyelid, strabismus